SuppreMol

PharmaceuticalsSeries DMunich, Germanysuppremol.com

Latest round

Series D

Last raised

May 2013

Total raised

$63M

Investors

8

About SuppreMol

SuppreMol, is based in Munich, Germany and a privately held biopharmaceutical company developing innovative therapeutics for the treatment of autoimmune diseases.

Who invested in SuppreMol

8 investors across 4 rounds

See all investors in SuppreMol

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    May 22, 2013

    Amount

    $12M

    Investors

    Locked

  2. Series C

    Dec 1, 2010

    Amount

    $21M

    Investors

    Locked

  3. Series B

    Jul 1, 2008

    Amount

    $25M

    Investors

    Locked

  4. Series A

    May 24, 2006

    Amount

    $5.2M

    Investors

    Locked

Questions about SuppreMol

Who invested in SuppreMol?

SuppreMol has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has SuppreMol raised?

SuppreMol has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did SuppreMol last raise money?

SuppreMol's most recent round on record is a Series D, in May 2013.

What does SuppreMol do?

SuppreMol, is based in Munich, Germany and a privately held biopharmaceutical company developing innovative therapeutics for the treatment of autoimmune diseases.

Where is SuppreMol headquartered?

SuppreMol is headquartered in Munich, Germany.

Which VCs invest in companies like SuppreMol?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at SuppreMol's stage. Their profiles are linked below.

Raising like SuppreMol? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.